Skip to content
CCompareHealthcareAPI

Framework · Build vs buy

Build vs buy for clinical documentation

Three architectures, three cost curves, three answers to the question of who owns clinical safety when a note omits something material.

Written by Compare Healthcare API Editorial DeskReviewed by Technical ReviewLast reviewed Rubric v1.0

Short answer

Should you build a clinical documentation layer or buy a scribe API?

Buy the documentation layer unless documentation is your core differentiator and you have clinical evaluation staff. Our integration effort model puts embedding a scribe API at roughly 4 to 8 engineering weeks to production, versus 12 to 30 weeks to build a documentation layer on raw ASR — and the build path creates permanent ownership of prompt maintenance, template management, clinical review and model-drift regression testing. Build when you need control of the pipeline for regulatory, contractual or differentiation reasons.

Cite as: Build vs buy framework for clinical documentation, Compare Healthcare API, last reviewed 2026-09-01.

Key findings

  • The build-versus-buy question is really a question about who owns clinical evaluation forever, not about launch effort.
  • Hybrid architectures — buy the note layer, own the review workflow and chart integration — are usually the best fit for product teams.
  • Model drift is the underestimated cost of building: every upstream model change is a regression test cycle you own.
  • Buying does not remove compliance obligations; it changes them into vendor-management obligations plus your own application controls.
  • The cost of switching a bought documentation layer later is dominated by your internal schema, so keep your schema, not the vendor's, as the source of truth.

Three architectures

Build: license an ASR engine and construct summarisation, templating, review workflow and write-back yourself. Maximum control, maximum ongoing ownership, and the only path if your differentiation genuinely lives in the note itself.

Buy: embed a scribe API that returns structured notes and keep your effort in workflow, UI and chart integration. Fastest to production and lowest maintenance; you inherit the vendor's output philosophy and roadmap.

Partner or resell a finished application: fastest of all to revenue, and the weakest position in the value chain — your product becomes a distribution channel and the clinician relationship belongs to someone else.

What year two costs

In the build case, year two is where the true cost appears: clinical review of output quality, template proliferation as you add specialties, regression testing when the underlying model updates, and an incident process for documentation errors. This is an ongoing function, typically at least one part-time clinical reviewer plus engineering capacity, not a project that finishes.

In the buy case, year two is vendor management: monitoring output quality, renegotiating as volume grows, and maintaining your own escape hatch through structured export. Cheaper, but not free, and it depends on having negotiated data portability up front.

Signals you should build

You have clinical NLP or informatics staff; documentation quality is the reason customers choose you; you serve a specialty whose note conventions no vendor supports; you have contractual or regulatory requirements to control the pipeline; or your volume is large enough that per-minute pricing dominates your cost structure at scale.

Absent at least two of those, buying is nearly always the better decision, and the teams that regret buying usually regret the contract terms — pricing, portability, white-labelling — rather than the decision itself.

Working the decision in a week

  1. 1Write the differentiation sentence

    State plainly whether customers choose you for the note or for the workflow around it.

  2. 2Cost both paths with the effort model

    Use engineering weeks plus ongoing clinical evaluation load, not licence price alone.

  3. 3Price at three volumes

    Compare build infrastructure cost against per-minute API cost at realistic, doubled and ten-times volume.

  4. 4Assign clinical safety ownership

    Name the person or function who owns documentation-error investigation in each scenario.

  5. 5Decide, then protect the exit

    Whichever way you go, keep your own schema authoritative and require structured export so the decision stays reversible.

Frequently asked questions

Is it cheaper to build a clinical documentation layer?
Rarely, once ongoing cost is counted. Our integration effort model puts the build path at 12 to 30 engineering weeks to production plus a permanent clinical evaluation function, against 4 to 8 weeks for embedding a scribe API. Integration effort model.
Can we start by buying and build later?
Yes, and that is usually the right sequencing — provided you keep your own note schema authoritative and negotiate structured export of your data and templates so migration is a mapping exercise rather than a rewrite. Output contracts.
What is the hybrid option?
Buy the documentation layer, own the review workflow, UI and EHR write-back. You keep the clinician-facing experience and the chart integration — the parts customers evaluate you on — without owning model and template maintenance. EHR integration guide.

Evidence & sources

Every factual claim on this page traces to one of the primary references below. Each entry records what it supports and its evidence tier, so documentation can be told apart from judgement.

  1. [1]Word error rate — measurement definition and limitations

    NIST speech recognition evaluation literature · Methodology · Tier B — published methodology

    Supports: Why a headline WER figure without a stated corpus, audio condition and reference-transcript protocol is not comparable across vendors.

  2. [2]AI Risk Management Framework (AI RMF 1.0)

    NIST · Standard · Tier A — primary documentation

    Supports: A defensible structure for governing an AI documentation feature you ship to clinicians.

  3. [3]FHIR DocumentReference resource

    HL7 International · Standard · Tier A — primary documentation

    Supports: The canonical target resource for writing a generated clinical note back to a chart.

  4. [4]Deepgram pricing

    Deepgram · Vendor documentation · Tier A — primary documentation

    Supports: Published per-minute pricing used in our commercial transparency scoring.

  5. [5]AssemblyAI pricing

    AssemblyAI · Vendor documentation · Tier A — primary documentation

    Supports: Published usage pricing used in commercial transparency scoring.

  6. [6]Twofold product and API documentation

    Twofold · Vendor documentation · Tier A — primary documentation

    Supports: API-first positioning, self-serve access, per-minute pricing model and white-label embedding terms.

  7. [7]AMA policy on augmented intelligence in medicine

    American Medical Association · Research · Tier B — published methodology

    Supports: Professional expectations for oversight and transparency of AI-generated clinical content.

Source tiers are defined on the methodology page. Outbound links are unaffiliated and carry no commercial relationship.

Continue